Dietary mildronate supplementation has no effect on carnitine biosynthetic enzyme mRNA expression in rat

Nutrition Research

Volumn 27, Issue 4, 2007, Pages 225-229

  Davis, Alan T ^a,b,c   Monroe, Thomas J ^b   Ingersoll, Kyle E ^b   VanWyk, Laura ^c   Wojtas, Mona ^c  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Spectrum Health ^*  (United States)

^c Clinical Nutrition Laboratory   (United States)

Author keywords

Butyrobetaine; Carnitine; Carnitine biosynthesis; Mildronate; Rat; Trimethyllysine

Indexed keywords

CARNITINE; GAMMA BUTYROBETAINE; GAMMA BUTYROBETAINE DIOXYGENASE; MESSENGER RNA; MILDRONATE; OXYGENASE; TRIMETHYLLYSINE HYDROXYLASE; UNCLASSIFIED DRUG;

AMINO ACID URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

ANIMALIA; RATTUS;

EID: 34147159740     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.01.014     Document Type: Article

References (19)

1. Vaz F.M., and Wanders R.J.A. Carnitine biosynthesis in mammals. Biochem J 361 (2002) 417-429
2. Paulson D.J. Carnitine deficiency-induced cardiomyopathy. Mol Cell Biochem 180 (1998) 33-41
3. Walter J.H. l-Carnitine. Arch Dis Child 74 (1996) 475-478
4. Davis A.T., and Hoppel C.L. Effect of starvation on the disposition of free and peptide-linked trimethyllysine in the rat. J Nutr 116 (1986) 760-767
5. Rebouche C.J., Lehman L.J., and Olson L. ε-N-trimethyllysine availability regulates the rate of carnitine biosynthesis in the growing rat. J Nutr 116 (1986) 751-759
6. Davis A.T., and Monroe T.J. Carnitine deficiency and supplementation do not affect the gene expression of carnitine biosynthetic enzymes in rats. J Nutr 135 (2005) 761-764
7. Simkhovich B.Z., Shutenko Z.V., Meirena D.V., Khagi K.B., Mezpuke R.J., Molodchina T.N., et al. 3-(2,2,2-trimethylhydrazinium) propionate (THP)-a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties. Biochem Pharmacol 37 (1988) 195-202
8. Tsoko M., Beauseigneur F., Gresti J., Niot I., Demarquoy J., Boichot J., et al. Enhancement of activities relative to fatty acid oxidation in the liver of rats depleted of l-carnitine by d-carnitine and a γ-butyrobetaine hydroxylase inhibitor. Biochem Pharmacol 49 (1995) 1403-1410
9. Spaniol M., Brooks H., Auer L., Zimmermann A., Solioz M., Stieger B., et al. Development and characterization of an animal model of carnitine deficiency. Eur J Biochem 268 (2001) 1876-1887
10. Galland S., Le Borgne F., Guyonne D., Clouet P., and Demarquoy J. Purification and characterization of the rat liver gamma-butyrobetaine hydroxylase. Mol Cell Biochem 178 (1998) 163-168
11. Peschechera A., Scalibastri M., Russo F., Giarrizzo M.G., Carminati P., Giannessi F., et al. Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life. Life Sci 77 (2005) 3078-3091
12. American Institute of Nutrition. Second report of the ad hoc committee on standards for nutritional studies. J Nutr 110 (1987) 1726
13. Tsoko M., Beauseigneur F., Gresti J., Demarquoy J., and Clouet P. Hypolipidaemic effects of fenofibrate are not altered by mildronate-mediated normalization of carnitine concentration in rat liver. Biochimie 80 (1998) 943-948
14. Degrace P., Demizieux L., Gresti J., Tsoko M., Andre A., Demaison L., et al. Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat. Mol Cell Biochem 258 (2004) 171-182
15. Davis A.T. Tissue trimethyllysine biosynthesis and carnitine content in pregnant and lactating rats fed a lysine-limiting diet. J Nutr 120 (1990) 846-856
16. Davis A.T. Assay of trimethyllysine hydroxylase by high performance liquid chromatography. J Chromatogr 422 (1987) 253-256
17. Vaz F.M., van Gool S., Ofman R., Ijlst L., and Wanders R.J.A. Carnitine biosynthesis: identification of the cDNA encoding human γ-butyrobetaine hydroxylase. Biochem Biophys Res Comm 250 (1998) 506-510
18. Georges B., Le Borgne F., Galland S., Isoir M., Ecosse D., Grand-Jean F., et al. Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate. Biochem Pharmacol 59 (2000) 1357-1363
19. Liepinsh E., Vilskersts R., Loca D., Kirjanova O., Pugovichs O., Kalvinsh I., et al. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. J Cardiovasc Pharmacol 48 (2006) 314-319